Mirror Exposure and D-Cycloserine Randomized Controlled Trial:
We are examining the added effect of a medication, d-cycloserine, which has been implicated in enhanced learning in exposure treatments for anxiety disorders—in mirror exposure for body image disturbance in individuals with eating disorders.
- Participants: 60 participants with eating disorders ages 18-55, 30 receiving d-cycloserine and 30 placebo
- Method: Baseline/psychiatric assessment, Psychoeducational session, 4-week mirror exposure treatment and administration of placebo/study drug, and 1 month follow up
Mirror Exposure Randomized Controlled Trial for Binge Eating and Bulimia Nervosa:
We are examining whether or not incorporating acceptance-based mirror exposure (A-MET) into standard treatment for eating disorders enhances treatment outcome.
- Participants: 60 participants with eating disorders ages 16-65
- Method: The study has a randomize-the-mediator design, in which participants undergo randomization at two different timepoints.
- Phase I: Randomization into Cognitive Behavioral Therapy-Enhanced (CBT-E) or Cognitive Behavioral Therapy- Guided Self-Help (CBT-GSH) for 10 weeks
- Phase II: Randomization into A-MET or Guided Self-Help Treatment for Body Shape and Weight Concerns
- 3- and 6-month follow ups
Neurocognitive function in children at risk for eating disorders
We are investigating whether children of mothers who have had an eating disorder at some point in their life have specific neuropsychological strengths and weaknesses in their thinking style.
- Participants: 20 healthy children aged 8-15 years whose mothers have had an eating disorder
- Method: cross-sectional study, one assessment of psychopathology and thinking styles (computerized games and puzzles).
For more information or to make an appointment:
1425 Madison Ave. (corner or 98th St. and Madison Ave.)
ICAHN Building, Floor 6, Room 32
New York, NY 10029